Related Experiment Video
Updated: Apr 23, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Recent advances in chronic granulomatous disease
1Institute of Child Health, University College London and The Great Ormond Street Hospital for Sick Children NHS Foundation Trust, 30 Guilford Street, London WC1N 1EH, UK.
Chronic Granulomatous Disease (CGD) is an immunodeficiency impacting microbe killing. New therapies like anti-TNF agents, stem cell transplants, and gene therapy offer hope for managing infections and inflammatory complications in CGD patients.
Area of Science:
- Immunology
- Genetics
- Hematology
Background:
- Chronic Granulomatous Disease (CGD) is a primary immunodeficiency.
- It stems from defects in the NADPH oxidase enzyme, crucial for the phagocytic respiratory burst.
- Recurrent infections and difficult-to-treat inflammatory complications are hallmarks of CGD.
Purpose of the Study:
- To review current and emerging therapeutic strategies for managing Chronic Granulomatous Disease.
- To highlight advancements in treating inflammatory complications and curative options for CGD.
Main Methods:
- Literature review of recent therapeutic developments for CGD.
- Analysis of treatment outcomes for anti-tumour necrosis factor agents, hematopoietic stem cell transplantation, and gene therapy.
Main Results:
- Anti-tumour necrosis factor agents show success in treating CGD colitis but carry infectious risks.
- Hematopoietic stem cell transplantation, including unrelated donor transplants, offers a potential cure with improving outcomes.
- Gene therapy presents a promising curative approach, pending the development of improved vectors.
Conclusions:
- Current therapeutic strategies for CGD involve managing infections and inflammatory complications.
- Hematopoietic stem cell transplantation and gene therapy represent significant advances towards a potential cure for CGD.
- Further research into vector development for gene therapy is essential for its widespread application.
More Related Videos
07:42A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas
Published on: June 5, 2014
03:53Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Related Concept Videos
Chronic Inflammation: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Cystic Fibrosis: Management
Sinus disease and chronic...